Get the latest Science News and Discoveries

Moderna mRNA vaccine almost halves the risk of skin cancer returning

Long-awaited results from phase III trial show a huge benefit in treating treatment-resistant melanoma.

None

Get the Android app

Or read this on Nature

Related news:

Aston University-led international study finds ADHD medication unlikely to raise risk of self-harm

Researchers say a world-first cancer vaccine is delivering results even better than they had hoped for. The “transformational” breakthrough is detailed in a study that found a 42% reduction in the risk of melanoma recurrence.

Here’s what the new Merck-Moderna mRNA cancer vaccine data actually show

« A tiny defect in a crystal reveals a big quantum surprise

'Stupendously large black holes' aren't a major component of dark matter, study finds »